FdaApplication

BLA 761404

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCELLTRION, Inc.
application_typeBLA
approval_date2025-02-28

Products (2)

ProductActive ingredientStrengthDosage form
OSENVELTDENOSUMAB-BMWO120MG/1.7ML (70MG/ML)Injection
STOBOCLODENOSUMAB-BMWO60MG/MLInjection

2 products